Navigation Links
Penn researchers uncover novel immune therapy for pancreatic cancer
Date:3/24/2011

es would turn on the T cells and allow them to attack the tumor.

The treatment appeared to work, with some patients' tumors shrinking substantially and the vast majority of tumors losing metabolic activity after therapy, although all of the responding patients eventually relapsed. When the researchers looked at post-treatment tumor samples, obtained via biopsy or surgical removal, there were no T cells to be seen. Instead, they saw an abundance of another white blood cell known as macrophages.

To understand what was happening in the tissues of these patients, Vonderheide and Beatty and colleagues turned to a mouse model of pancreatic cancer developed several years ago at Penn. Unlike older mouse models that were simplistic models of human disease, new genetically engineered mice develop spontaneous cancers that are very close reproductions of human tumors. "We can perform preclinical trials in these mice with the same principles we use in our patients," Vonderheide says, noting that the team even used a randomization protocol to assign individual mice to different arms of the study.

When the investigators treated mice that developed pancreatic cancer with gemcitabine in combination with CD40 antibodies, the results looked like those of the human trial. Some mouse tumors shrank and were found to be loaded with macrophages but contained few or no T cells. Closer inspection showed that the macrophages were attacking what is known as the tumor stroma, the supporting tissue around the tumor. Pancreatic tumors secrete chemical signals that draw macrophages to the tumor site, but if left to their own devices, these macrophages would protect the tumor. However, treating the mice (or patients) with CD40 antibodies seemed to flip that system on its head. "It is something of a Trojan horse approach," Vonderheide says. "The tumor is still calling in macrophages, but now we've used the CD40 receptor to re-educate those macrophages to attack not promote
'/>"/>

Contact: Holly Auer
holly.auer@uphs.upenn.edu
215-200-2313
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
2. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
3. Researchers discover new way to kill pediatric brain tumors
4. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
5. Researchers create drug to keep tumor growth switched off
6. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
7. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
8. Clemson researchers develop hands-free texting application
9. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
10. Researchers chart genomic map spanning over 2 dozen cancers
11. Researchers discover second protective role for tumor-suppressor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... ... Many Fourth of July celebrations will include fireworks this summer, so it’s ... some tips to promote the proper use of fireworks. , According to the U.S. ... with fireworks-related injuries in the month surrounding the Fourth of July. Amica is sharing ...
(Date:7/2/2015)... , ... July 02, 2015 , ... As Americans celebrate ... the hot temps, skin cancer is on the rise. July is UV Safety Month, ... raising awareness about the importance of getting skin checks. Experts say most skin cancers ...
(Date:7/2/2015)... ... ... The ZAC Foundation, a national leader in water safety education and drowning ... stay water safe with the help of a young polar bear named Zeke. ... follows Zeke’s water safety journey. Zeke, who is afraid of the water and ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... R. Krishnareddy, M.D., to the orthopedic and spine surgery team at their Anaheim ... strains, bursitis, and tendonitis. Along with the spine and spine surgery, Dr. Krishnareddy ...
(Date:7/2/2015)... York, NY (PRWEB) , ... July 02, 2015 ... ... City for Carpal Tunnel treatment and wrist pain treatment. Dr. Lev Kalika, founder ... NYDNRehab – and a leading international authority on the conservative treatment of back, ...
Breaking Medicine News(10 mins):Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4
... FRANCISCO, Sept. 3 Blue Shield of California announced today that ... health services for Blue Shield members impacted by the fires in ... difficult time, we want to make it as easy as possible ... access to the medical services they need," said Meredith Mathews, M.D., ...
... , , NEW YORK, Sept. 3 ... Month by enhancing the support services already available to its group life ... affected by the loss of a loved one - The Healing ... (written by Ellen Sabin and published by Watering Can Press). , ...
... , , , OKLAHOMA ... located in Oklahoma City, today announced that it has partnered ... providers of specialty surgical services. Surgical Hospital of Oklahoma is ... inpatient acute care in a number of specialties including pain ...
... higher than with seasonal flu , THURSDAY, Sept. 2 ... complications from the H1N1 swine flu since the virus ... younger than 18, a new government report shows. , ... at least one chronic high-risk "neurodevelopmental condition," such as ...
... Positive interaction beats punishment when trying to reach a goal, ... Trying to determine the best way to get people to ... Economics have found that a carrot is better than a ... with each other to solve a group social dilemma, our ...
... , NEW YORK, Sept. 3 Reportlinker.com announces that a ... Cosmetic Surgery Markets: Products and Services ... REPORT HIGHLIGHTS , , , ... billion in 2008, a figure that is expected to reach $40.1 billion ...
Cached Medicine News:Health News:Blue Shield of California Streamlines Access to Benefits and Prescriptions for Wildfire Victims 2Health News:Anthem Life & Disability Insurance Company offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with the Loss of a Loved One 2Health News:Surgical Hospital of Oklahoma to Partner with Surgical Care Affiliates 2Health News:Swine Flu Poses Risk to Kids With Neurological Conditions 2Health News:Swine Flu Poses Risk to Kids With Neurological Conditions 3Health News:Swine Flu Poses Risk to Kids With Neurological Conditions 4Health News:Rewards Are Key to Cooperation 2Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 2Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 3Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 4Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 5Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 6Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 7Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 8Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 9Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 10Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 11Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 12Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 13Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 14Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 15Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 16Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 17
(Date:7/2/2015)... 25, 2015 Research and ... "Veterinary / Animal Vaccines Market by Product, Diseases ... to their offering. The global animal vaccines ... from $5,507.3 Million in 2015, at a CAGR of ... fueling market growth are growing prevalence of animal diseases, ...
(Date:7/2/2015)... , July 2, 2015 Legal-Bay LLC, ... District Judge Joseph Goodwin in the Southern ... consolidated 26 transvaginal mesh cases against Ethicon for a ... . The cases for the 26 women include claims ... a device made my Johnson & Johnson,s Ethicon subsidiary. ...
(Date:7/2/2015)... , July 2, 2015 ... to improving access to HIV treatments   ... strategic manufacturing agreement to enable production in China ... source of the dolutegravir active pharmaceutical ingredient (API), and will ... finished product (dolutegravir 50mg, marketed under the name Tivicay®) for ...
Breaking Medicine Technology:Veterinary / Animal Vaccines Market 2015 - Global Forecast to 2020 for the $7.19 Billion Industry 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6
... indicate statistically significant improvement in ACR20 responses over ... MEDX ) today announced that the ... active rheumatoid arthritis (RA) receiving methotrexate successfully met ... recently completed 70-patient multi-center, randomized, double-blind, placebo-controlled Phase ...
... DIEGO, May 14 Cadence Pharmaceuticals, Inc. ... has submitted a New Drug Application (NDA) to the ... product candidate, Acetavance(TM) (intravenous acetaminophen), for the treatment of ... approved, Acetavance would become the first new intravenous analgesic ...
Cached Medicine Technology:Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 2Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 3Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 4Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever 2Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever 3Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever 4Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever 5
For the quantitative in vitro determination of IgE in Human Serum or Plasma....
For the quantitative in vitro determination of IgG in serum and plasma. This product is suitable for use on the Aeroset...
Latex-enhanced immunoturbidimetric assay for the quantitative in vitro determination of C-reactive protein in serum and plasma...
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of CRP in serum....
Medicine Products: